Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Verónica Torres-Solórzano has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of case: Monitoring of the method of decontamination with chlorine dioxide in rooms previously occupied by patients colonized with multidrug-resistant Acinetobacter

    by Manuel Aparicio-Alonso, Alma Guadalupe Avalos-Contreras, Verónica Torres-Solórzano

    Contamination of hospital surfaces by patients colonized with Acinetobacter represents a risk of nosocomial infections. The imperative need to prevent intrahospital transmission and dissemination has prompted the implementation of approved agents with high biocidal capacity and low toxicity. In one hospital, it was documented in real time the safety of decontamination with ClO2 at 60 ppm for 30 minutes in unoccupied inpatient rooms by antimicrobial culture and ATP bioluminescence assays. After decontamination, sampling of surfaces occupied by patients colonized with Acinetobacter, no viable culturable spores or metabolic activity was reported. At follow-up, previous and subsequent patients did not develop Acinetobacter infections, and no sign of microbiological contamination was observed after room decontamination. These results suggest that ClO2 can be used as a safe and economical antimicrobial agent with feasibility for integration into medical practices

  • Open Access

    Case report: Resolution of pathologic fracture from metastatic non-Hodgkin's lymphoma with compassionate therapy

    by Manuel Aparicio-Alonso, Verónica Torres-Solórzano

    Broad-spectrum anticancer treatments have limited cell selectivity. The sites of action of these treatments are targeted at blocking cell division and inducing apoptosis. This has a negative impact on the viability and proliferation of healthy cells, which can cause deterioration in the patient's quality of life. In this case report, an older patient with non-Hodgkin's lymphoma, follicular pattern grade 2 with invasion to the L3 vertebra, concluded a combination chemotherapy regimen of cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP). However, the patient reported severe and prolonged adverse reactions that caused physical and emotional complaints, thus she refused to continue with the subsequent radiotherapy. Given the impact on quality of life and uncertain survival, by personal decision, the patient started compassionate therapy based on chlorine dioxide (ClO2). This low-cost anticancer agent causes apoptosis in cancer cells by destabilizing the oxidative balance through the release of reactive oxygen species. ClO2 treatment was administered orally and by enema at a concentration below the EPA-reported toxicity threshold, in order to not compromise healthy cells, given that they do not experience the high levels of oxidative stress of cancer cells. During ClO2 treatment, the patient reported no adverse reactions and an increase in bone density was observed in pathological terrain. Rigorous clinical studies are needed to analyze the temporal sequence of the increase in bone density

  • Open Access

    Case Report: Compassionate application of chlorine dioxide-based solution in a patient with metastatic prostate cancer

    by Manuel Aparicio-Alonso, Verónica Torres-Solórzano

    Chlorine dioxide is a powerful and cost-effective oxidizing agent that has demonstrated anti-cancer activity both in vitro and in vivo. Its proposed mechanism involves the release of free radicals, which disrupt the delicate oxidative balance within cancer cells. In case report, the patient has voluntarily opted for compassionate chlorine dioxide therapy over continuing conventional chemotherapy and immunotherapy due to side effects and uncertain survival outcomes. The concentration of the chlorine dioxide solution was 1/100 times lower than the LOAEL threshold, ensuring that not compromise the patients' health. This is the first follow-up in patient diagnosed with metastatic prostate cancer, who shown tumor reduction at distant sites from the primary tumor with no side effects. This preliminary observation suggests that chlorine dioxide and its free radicals could be potential mediators of an anticancer response. However, it is imperative to emphasize the importance of conducting rigorous clinical trials to validate these initial findings


  • Open Access

    Scanning Electron Microscopy and EDX Spectroscopy of Commercial Swabs Used for COVID-19 Lateral Flow Testing

    by Manuel Aparicio-Alonso, Verónica Torres-Solórzano, José Francisco Méndez-Contreras, Karina Acevedo-Whitehouse

    The chemical composition of COVID test swabs has not been examined beyond the manufacturer’s datasheets. The unprecedented demand for swabs to conduct rapid lateral flow tests and nucleic acid amplification tests led to mass production, including 3D printing platforms. Manufacturing impurities could be present in the swabs and, if so, could pose a risk to human health. We used scanning electron microscopy and energy dispersive X-ray (EDX) spectroscopy to examine the ultrastructure of seven assorted brands of COVID test swabs and to identify and quantify their chemical elements. We detected eight unexpected elements, including transition metals, such as titanium and zirconium, the metalloid silicon, as well as post-transition metals aluminium and gallium, and the non-metal elements sulphur and fluorine. Some of the elements were detected as trace amounts, but for others, the amount was close to reported toxicological thresholds for inhalation routes. Experimental studies have shown that the detrimental effects of unexpected chemical elements include moderate to severe inflammatory states in the exposed epithelium as well as proliferative changes. Given the massive testing still being used in the context of the COVID pandemic, we urge caution in continuing to recommend repeated and frequent testing, particularly of healthy, non-symptomatic, individuals.